EUR 2.85
(-2.9%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -41.42 Million CAD | 42.71% |
2022 | -72.31 Million CAD | -287.22% |
2021 | -18.67 Million CAD | -2445.98% |
2020 | 796 Thousand CAD | 104.01% |
2019 | -19.87 Million CAD | -432.28% |
2018 | -3.73 Million CAD | -489.4% |
2017 | 958.83 Thousand CAD | -40.94% |
2016 | 1.62 Million CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q3 | 3.05 Million CAD | 53.75% |
2024 Q2 | 1.98 Million CAD | -28.83% |
2024 Q1 | 2.79 Million CAD | 139.66% |
2023 Q3 | 651 Thousand CAD | 124.64% |
2023 Q2 | -2.64 Million CAD | 32.64% |
2023 Q1 | -3.92 Million CAD | 92.74% |
2023 FY | -41.42 Million CAD | 42.71% |
2023 Q4 | 1.16 Million CAD | 78.96% |
2022 Q3 | -4.67 Million CAD | 38.37% |
2022 Q1 | -6.14 Million CAD | -26.72% |
2022 Q4 | -54 Million CAD | -1056.42% |
2022 FY | -72.31 Million CAD | -287.22% |
2022 Q2 | -7.57 Million CAD | -23.28% |
2021 Q1 | -2.04 Million CAD | -457.52% |
2021 Q3 | -7.26 Million CAD | -61.1% |
2021 Q4 | -4.85 Million CAD | 33.25% |
2021 Q2 | -4.51 Million CAD | -120.59% |
2021 FY | -18.67 Million CAD | -2445.98% |
2020 FY | 796 Thousand CAD | 104.01% |
2020 Q2 | 57 Thousand CAD | 102.93% |
2020 Q4 | 572 Thousand CAD | -72.89% |
2020 Q1 | -1.94 Million CAD | 70.68% |
2020 Q3 | 2.11 Million CAD | 3601.75% |
2019 Q3 | -4.03 Million CAD | 11.87% |
2019 FY | -19.87 Million CAD | -432.28% |
2019 Q4 | -6.62 Million CAD | -64.09% |
2019 Q2 | -4.58 Million CAD | 8.42% |
2019 Q1 | -5 Million CAD | -64.6% |
2018 Q3 | -707 Thousand CAD | 1.94% |
2018 Q2 | -721 Thousand CAD | -255.19% |
2018 FY | -3.73 Million CAD | -489.4% |
2018 Q4 | -3.03 Million CAD | -329.95% |
2018 Q1 | 464.58 Thousand CAD | 45.28% |
2017 Q3 | 756.68 Thousand CAD | 0.0% |
2017 Q4 | 319.77 Thousand CAD | -57.74% |
2017 FY | 958.83 Thousand CAD | -40.94% |
2016 FY | 1.62 Million CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Newron Pharmaceuticals S.p.A. | -11.62 Million EUR | -256.222% |
Redcare Pharmacy NV | -16.73 Million EUR | -147.461% |